Holzer & Holzer, LLC announced an investigation into whether AdaptHealth Corp. complied with federal securities laws. On August 4, 2026, AdaptHealth revised its financial guidance and reported second quarter results, disclosing that cash flow from operations fell to $239.0 million year-to-date 2026 from $257.5 million in the comparable 2025 period, while free cash flow turned negative to negative $48.4 million from $73.3 million. The company attributed the decline partly to its West Coast capitated partnership reaching full scale and the complexity of the transition impacting margins. Following the news, AdaptHealth's stock price dropped. The law firm encourages investors who purchased AdaptHealth stock and suffered a loss to contact Corey Holzer or Joshua Karr to discuss their legal rights.
Adapthealth CorpRevised guidance and negative free cash flow decline trigger securities investigation and stock drop.